Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone.
Bonoan
J T
JT
Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501, USA.
Johnson
D H
DH
Cunha
B A
BA
D000743:Anemia, Hemolytic / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D053626:Atovaquone; D017963:Azithromycin / Q000008:administration & dosage*; D001404:Babesiosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D016638:Critical Illness; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009285:Naphthoquinones / Q000008:administration & dosage*; D013154:Spleen / Q000002:abnormalities*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D017963:Azithromycin; D053626:Atovaquone